1998
DOI: 10.1046/j.1365-2265.1998.3811205.x
|View full text |Cite
|
Sign up to set email alerts
|

Carrier status for steroid 21‐hydroxylase deficiency is only one factor in the variable phenotype of acne

Abstract: Although alterations of the CYP21 gene were more common in acne than in controls there is a poor correlation between these events and raised steroids and acne. Factors other than mild impairment of CYP21 contribute to the variability of the clinical phenotype in hyperandrogenic states including acne.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
31
2
6

Year Published

1998
1998
2019
2019

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 62 publications
(40 citation statements)
references
References 34 publications
1
31
2
6
Order By: Relevance
“…This is in agreement with observations that heterozigosity for CYP21 mutations may result in mild abnormalities of androgen biosynthesis reflected by higher mean free testosterone (13,30) or by higher mean DHEAS concentrations (10). Our results suggest that, in contrast with findings in patients with NC-CAH, among hyperandrogenic women, basal or ACTHstimulated 17-OHP concentrations are not a good indicator of the carrier status for inherited defects of CYP21, as observed also by other investigators (13,31,32) who defined the carrier status by molecular analysis of CYP21 gene, the most accurate method to define carriers for inherited defects of CYP21 (10). Older studies reported that the majority of heterozygotes for 21-hydroxylase deficiency can be detected by measuring the 17-OHP concentration 60 min after ACTH stimulation; however, the diagnosis of 21-hydroxylase deficiency was based on HLA genotyping (33 It remains unclear what was the cause of borderline elevations in ACTH-stimulated 17-OHP concentrations in nine of 12 hyperandrogenic patients (75%), in whom even extensive sequencing of the CYP21 gene and its proximal promoter region revealed no mutations.…”
Section: Discussioncontrasting
confidence: 57%
“…This is in agreement with observations that heterozigosity for CYP21 mutations may result in mild abnormalities of androgen biosynthesis reflected by higher mean free testosterone (13,30) or by higher mean DHEAS concentrations (10). Our results suggest that, in contrast with findings in patients with NC-CAH, among hyperandrogenic women, basal or ACTHstimulated 17-OHP concentrations are not a good indicator of the carrier status for inherited defects of CYP21, as observed also by other investigators (13,31,32) who defined the carrier status by molecular analysis of CYP21 gene, the most accurate method to define carriers for inherited defects of CYP21 (10). Older studies reported that the majority of heterozygotes for 21-hydroxylase deficiency can be detected by measuring the 17-OHP concentration 60 min after ACTH stimulation; however, the diagnosis of 21-hydroxylase deficiency was based on HLA genotyping (33 It remains unclear what was the cause of borderline elevations in ACTH-stimulated 17-OHP concentrations in nine of 12 hyperandrogenic patients (75%), in whom even extensive sequencing of the CYP21 gene and its proximal promoter region revealed no mutations.…”
Section: Discussioncontrasting
confidence: 57%
“…The first systematic molecular genetic analyses of a genetic predisposition to acne were performed only in the 1990s [33][34][35], and since that time only a small number of publications have emerged. Most of the genes studied so far are either key players of innate immune events during lesion formation or have a function in steroid hormone metabolism (Table 1); recently additional polymorphisms and mutations that can be linked to cellular metabolic processes have been published.…”
Section: Molecular Genetic Studiesmentioning
confidence: 99%
“…Several candidate genes have thus far been implicated, which include tumour necrosis factor (TNF) 10,11 , tumour necrosis factor receptor 2 (TNFR2) 12 , tolllike receptor 2 (TLR2) 12 , interleukin 1-alpha (IL-1a) 13 , cytochrome P450 family 1 subfamily A polypeptide 1 (CYP1A1) 14 , cytochrome P450 family 17 subfamily A polypeptide 1 (CYP17A1) 15 , cytochrome P450 family 21 subfamily A polypeptide 2 (CYP21A2) 16 and androgen receptor (AR) 17 . These genes affect two major cellular processes: regulation of steroid hormone metabolism and the innate immune functions of epidermal keratinocytes.…”
mentioning
confidence: 99%